These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2309251)

  • 1. A physiological pharmacokinetic model describing the disposition of lead in the absence and presence of L-ascorbic acid in rats.
    Dalley JW; Gupta PK; Hung CT
    Toxicol Lett; 1990 Feb; 50(2-3):337-48. PubMed ID: 2309251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of L-ascorbic acid on the disposition of lead in rats.
    Dalley JW; Gupta PK; Lam FC; Hung CT
    Pharmacol Toxicol; 1989 Apr; 64(4):360-4. PubMed ID: 2748544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lead administration on L-ascorbic acid metabolism in rats: effect of L-ascorbic acid supplementation.
    Rudra PD; Chatterjee J; Chatterjee GC
    Int J Vitam Nutr Res; 1975; 45(4):429-37. PubMed ID: 1213870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid disposition kinetics in the plasma and tissues of calves.
    Toutain PL; Béchu D; Hidiroglou M
    Am J Physiol; 1997 Nov; 273(5):R1585-97. PubMed ID: 9374798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats.
    Patra RC; Swarup D; Dwivedi SK
    Toxicology; 2001 May; 162(2):81-8. PubMed ID: 11337108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lipid peroxidation and ascorbic Acid utilization in testis and epididymis of rats chronically exposed to lead.
    Marchlewicz M; Wiszniewska B; Gonet B; Baranowska-Bosiacka I; Safranow K; Kolasa A; Głabowski W; Kurzawa R; Jakubowska K; Rać ME
    Biometals; 2007 Feb; 20(1):13-9. PubMed ID: 16699871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats.
    McNiff EF; Cheng LK; Woodfield HC; Fung HL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):131-7. PubMed ID: 663395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential in vitro effects of homoarginine on oxidative stress in plasma, erythrocytes, kidney and liver of rats in the absence and in the presence α-tocopherol, ascorbic acid or L-NAME.
    Sasso S; Dalmedico L; Magro DD; Pereira EM; Wyse AT; de Lima DD
    Amino Acids; 2015 Sep; 47(9):1931-9. PubMed ID: 25894889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of N-acetylprocainamide disposition kinetics in rat by combination of gamma variate and physiological pharmacokinetic model.
    Liu XD; Deng N; Huang SK
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):97-103. PubMed ID: 1376015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of L-ascorbic acid in rats under in vivo administration of mercury: effect of L-ascorbic acid supplementation.
    Chatterjee GC; Pal DR
    Int J Vitam Nutr Res; 1975; 45(3):284-92. PubMed ID: 1184293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid and EDTA treatment of lead toxicity in rats.
    Goyer RA; Cherian MG
    Life Sci; 1979 Jan; 24(5):433-8. PubMed ID: 107387
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioural and neurotoxic effects of L-ascorbic acid and L-tryptophan in lead exposed rats.
    Ebuehi OA; Ayinde OC
    Nig Q J Hosp Med; 2012; 22(4):240-4. PubMed ID: 24568057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.
    Graumlich JF; Ludden TM; Conry-Cantilena C; Cantilena LR; Wang Y; Levine M
    Pharm Res; 1997 Sep; 14(9):1133-9. PubMed ID: 9327438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic model to describe the disposition of lead in the rat.
    Bornemann LD; Colburn WA
    J Toxicol Environ Health; 1985; 16(3-4):631-9. PubMed ID: 4087323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling.
    Shin BS; Bulitta JB; Balthasar JP; Kim M; Choi Y; Yoo SD
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):465-75. PubMed ID: 21069337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat.
    Plowchalk DR; Andersen ME; deBethizy JD
    Toxicol Appl Pharmacol; 1992 Oct; 116(2):177-88. PubMed ID: 1412462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.